189 related articles for article (PubMed ID: 9920067)
1. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease.
Costagliola S; Morgenthaler NG; Hoermann R; Badenhoop K; Struck J; Freitag D; Poertl S; Weglöhner W; Hollidt JM; Quadbeck B; Dumont JE; Schumm-Draeger PM; Bergmann A; Mann K; Vassart G; Usadel KH
J Clin Endocrinol Metab; 1999 Jan; 84(1):90-7. PubMed ID: 9920067
[TBL] [Abstract][Full Text] [Related]
2. Are porcine and human TSH receptor antibody measurements comparable?
Zöphel K; von Landenberg P; Roggenbuck D; Wunderlich G; Kotzerke J; Lackner KJ
Clin Lab; 2008; 54(1-2):1-8. PubMed ID: 18510037
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
Giovanella L; Ceriani L; Garancini S
Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
[TBL] [Abstract][Full Text] [Related]
4. [Measurement of thyrotropin receptor antibodies (TRAK) with a second generation assay in patients with Graves' disease].
Zöphel K; Wunderlich G; Koch R; Franke WG
Nuklearmedizin; 2000; 39(4):113-20. PubMed ID: 10919162
[TBL] [Abstract][Full Text] [Related]
5. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
6. On specificity of 2nd generation TSH receptor autoantibody measurements.
Zöphel K; Grüning T; Roggenbuck D; Wunderlich G; Kotzerke J
Clin Lab; 2008; 54(7-8):243-9. PubMed ID: 18942492
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a coated-tube assay for antithyrotropin receptor antibodies in patients with Graves' disease and other thyroid disorders.
Cardia MS; Lima N; Knobel M; Medeiros-Neto G
Thyroid; 2004 Apr; 14(4):295-300. PubMed ID: 15142363
[TBL] [Abstract][Full Text] [Related]
8. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
Morgenthaler NG; Ho SC; Minich WB
J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
[TBL] [Abstract][Full Text] [Related]
9. A new assay for thyrotropin receptor autoantibodies.
Smith BR; Bolton J; Young S; Collyer A; Weeden A; Bradbury J; Weightman D; Perros P; Sanders J; Furmaniak J
Thyroid; 2004 Oct; 14(10):830-5. PubMed ID: 15588379
[TBL] [Abstract][Full Text] [Related]
10. Continuously increasing sensitivity over three generations of TSH receptor autoantibody assays.
Zöphel K; Roggenbuck D; Wunderlich G; Schott M
Horm Metab Res; 2010 Nov; 42(12):900-2. PubMed ID: 20925015
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial.
Schott M; Hermsen D; Broecker-Preuss M; Casati M; Mas JC; Eckstein A; Gassner D; Golla R; Graeber C; van Helden J; Inomata K; Jarausch J; Kratzsch J; Miyazaki N; Moreno MA; Murakami T; Roth HJ; Stock W; Noh JY; Scherbaum WA; Mann K
Clin Endocrinol (Oxf); 2009 Oct; 71(4):566-73. PubMed ID: 19170704
[TBL] [Abstract][Full Text] [Related]
12. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays.
Pedersen IB; Knudsen N; Perrild H; Ovesen L; Laurberg P
Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682
[TBL] [Abstract][Full Text] [Related]
13. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
[TBL] [Abstract][Full Text] [Related]
14. Bridge Technology with TSH Receptor Chimera for Sensitive Direct Detection of TSH Receptor Antibodies Causing Graves' Disease: Analytical and Clinical Evaluation.
Frank CU; Braeth S; Dietrich JW; Wanjura D; Loos U
Horm Metab Res; 2015 Nov; 47(12):880-8. PubMed ID: 26079838
[TBL] [Abstract][Full Text] [Related]
15. TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays.
Zöphel K; Roggenbuck D; von Landenberg P; Wunderlich G; Grüning T; Kotzerke J; Lackner KJ; Rees Smith B
Horm Metab Res; 2010 Jan; 42(1):65-9. PubMed ID: 19830651
[TBL] [Abstract][Full Text] [Related]
16. Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation.
Schott M; Feldkamp J; Bathan C; Fritzen R; Scherbaum WA; Seissler J
Horm Metab Res; 2000 Oct; 32(10):429-35. PubMed ID: 11069209
[TBL] [Abstract][Full Text] [Related]
17. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
[TBL] [Abstract][Full Text] [Related]
18. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
Hill BL; Erlanger BF
Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
[TBL] [Abstract][Full Text] [Related]
20. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
